机译:低强化化学疗法的两年临床结果,用于低风险HPV相关的口咽鳞状细胞癌
Univ N Carolina Sch Med Chapel Hill NC USA;
Univ Florida Coll Med Dept Radiat Oncol Gainesville FL USA;
Univ N Carolina Chapel Hill NC USA;
Univ N Carolina Chapel Hill NC USA;
Univ N Carolina Sch Med Chapel Hill NC USA;
Univ N Carolina Chapel Hill NC USA;
Univ N Carolina Sch Med Chapel Hill NC USA;
Univ North Carolina Hosp Chapel Hill NC USA;
Univ North Carolina Hosp Chapel Hill NC USA;
Univ North Carolina Hosp Chapel Hill NC USA;
Univ North Carolina Hosp Chapel Hill NC USA;
Univ North Carolina Hosp Rex Raleigh NC USA;
Univ North Carolina Hosp Chapel Hill NC USA;
Univ Florida Coll Med Dept Radiat Oncol Gainesville FL USA;
机译:低强化化学疗法的两年临床结果,用于低风险HPV相关的口咽鳞状细胞癌
机译:用于低风险HPV相关的口咽鳞状细胞癌的去强化化学疗法的第2期前瞻性试验的初始结果
机译:用于低风险HPV相关的口咽鳞状细胞癌的去强化化学疗法的第2期前瞻性试验的初始结果
机译:Zeste同源2的增强子的上调与Cyclin Dl过度表达和头颈部鳞状细胞癌的不良临床结果呈正相关。
机译:乳酸乳酸增加了Hraasg12V - 阳性口咽鳞状细胞癌中的免疫检查点难以表达
机译:增强化学放疗治疗吞咽功能与HPV相关的口咽鳞状细胞癌
机译:用于低风险HPV相关的口咽鳞状细胞癌的去强化化学疗法的第2期前瞻性试验的初始结果